REJUVERON LIFE SCIENCES
Rejuveron Life Sciences AG is a fully integrated biotechnology platform company that invests in people and ideas to develop therapies and technologies to improve healthy aging and prolong lifespan.
REJUVERON LIFE SCIENCES
Social Links:
Industry:
Biotechnology Health Care Medical
Founded:
2019-01-01
Status:
Active
Email Addresses:
[email protected]
Total Funding:
25.01 M USD
Technology used in webpage:
Content Delivery Network Metanet
Similar Organizations
Rakuten Medical
Rakuten Medical is a Bio-technology Company.
Knopp Biosciences
Knopp Neurosciences is a drug discovery and development company working on treatments for neurological disorders.
Remix Therapeutics
Remix Therapeutics is a biotechnology company.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Employees Featured
Founder
Investors List
What If Ventures
What If Ventures investment in Series B - Rejuveron Life Sciences
re.Mind Capital
re.Mind Capital investment in Series B - Rejuveron Life Sciences
Apeiron Investment Group
Apeiron Investment Group investment in Series B - Rejuveron Life Sciences
Gaingels
Gaingels investment in Series B - Rejuveron Life Sciences
Ava Investors
Ava Investors investment in Series B - Rejuveron Life Sciences
10X Capital
10X Capital investment in Series A - Rejuveron Life Sciences
Korify Capital AG
Korify Capital AG investment in Series A - Rejuveron Life Sciences
infinitas capital group
infinitas capital group investment in Series A - Rejuveron Life Sciences
Gaingels
Gaingels investment in Series A - Rejuveron Life Sciences
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-12-13 | Endogena | Rejuveron Life Sciences investment in Series A - Endogena | 21 M USD |
| 2021-10-12 | Rejuvenate Biomed | Rejuveron Life Sciences investment in Series B - Rejuvenate Biomed | 15.7 M EUR |
| 2021-01-28 | Endogena | Rejuveron Life Sciences investment in Series A - Endogena | 8 M USD |
Key Employee Changes
| Date | New article |
|---|---|
| 2021-11-19 | Rejuveron Appoints Roche Veteran Bob Silverman as Chief Business Officer and Opens US Operations in New York |
More informations about "Rejuveron Life Sciences" on Search Engine
What we do – Rejuveron
What we do – Rejuveron. Rejuveron supports pioneers in the field of aging to transform their scientific discoveries into medicines. We are building a product pipeline comprised …See details»
How we work – Rejuveron
We aim to make pioneering discoveries by enabling talented drug-hunters to focus on the serious business of their science. Our teams reinforce each other, encouraging people …See details»
Rejuveron Life Sciences - Crunchbase Investor Profile
Company Type For Profit. Contact Email [email protected]. Phone Number +41 44 730 12 90. Rejuveron Life Sciences AG is a fully integrated biotechnology platform company …See details»
Rejuvenate Biomed - €15.7 million Series B round secured
Rejuveron Life Sciences AG is a fully integrated biotechnology platform company that invests in people and ideas to develop therapies and technologies to improve healthy …See details»
Our purpose - backend.rejuveron.com
We aim to prevent and reverse the Hallmarks of again. One of our goals is speed to market in the field of senescence. We work with longevity therapeutics, Incubator, longevity …See details»
Rejuveron Transitions to Become a Clinical Stage Company as …
Mar 28, 2022 Rejuveron Life Sciences AG (‘Rejuveron’), a Zürich-based biotechnology company developing therapies to promote healthy aging, today announced that …See details»
Creating therapies for improved aging and longer lives - Nature
Rejuveron, based in Zürich, Switzerland, and founded in 2019, is an integrated biotechnology company that aims to deliver innovative therapies and technologies to …See details»
Mubadala, Hedge Fund Tycoons Finance Longevity Biotech …
September 12, 2023 at 3:54 AM PDT. Listen. 2:14. Swiss biotech firm Rejuveron Life Sciences AG has attracted backing from sovereign fund Mubadala Investment Co. to …See details»
Rejuveron Increases to Near-majority Stake in Endogena …
ZÜRICH, Switzerland, Dec. 13, 2021 /PRNewswire/ -- Rejuveron Life Sciences AG, a Zürich-based biotechnology company developing technologies for healthy aging, today …See details»
Rejuveron Life Sciences AG | LinkedIn
Rejuveron Life Sciences AG | 4,892 followers on LinkedIn. Helping people live longer, healthier lives. | Rejuveron is a clinical-stage biotechnology company creating therapies …See details»
Rejuveron Telomere Therapeutics – Rejuveron
At Rejuveron Telomere Therapeutics we aim to restore the function of telomeres in age-related disorders. By combining the latest research discoveries with Rejuveron’s state-of …See details»
Rejuveron Company Profile 2024: Valuation, Funding & Investors …
Rejuveron Overview. Update this profile. Year Founded. 2019. Status. Private. Employees. 18. Latest Deal Type. Series B. Latest Deal Amount. $75M. Investors. 23. General …See details»
Rejuveron Life Sciences - Funding, Financials, Valuation & Investors
Rejuveron Life Sciences has raised a total of. $100.1M. in funding over 6 rounds. Their latest funding was raised on Sep 13, 2023 from a Series B round. Rejuveron Life …See details»
Rejuveron invests in Begium-based Rejuvenate Biomed to …
Oct 12, 2021 Rejuveron Life Sciences AG (‘Rejuveron’), a Zürich-based biotechnology company developing therapies to promote healthy aging, today announced that it will …See details»
Defining a longevity biotechnology company - Nature
Jun 26, 2023 The Longevity Biotechnology Association (LBA) is a non-profit organization created to foster collaboration, propose guidelines for industry, educate …See details»
Rejuveron Appoints Roche Veteran Bob Silverman as Chief …
Nov 19, 2021, 02:00 ET. Share this article. ZURICH and NEW YORK, Nov. 19, 2021 /PRNewswire/ -- Rejuveron Life Sciences AG, a Zürich-based biotechnology company …See details»
Abu Dhabi’s Mubadala invests in Swiss longevity biotech firm …
Sep 13, 2023 Cleofe Maceda, ZAWYA. September 13, 2023. Abu Dhabi sovereign wealth fund Mubadala is investing in Swiss biotech firm Rejuveron Life Sciences AG. …See details»
Rejuveron Life Sciences AG | VentureRadar
Founded in 2019. Private Company. Develops clinical-stage biotechnology therapies for healthy aging using advanced biopharmaceutical R&D and a deep understanding of …See details»
Rejuveron Life Sciences - Investments, Portfolio & Company Exits
Start Your Free Trial. Rejuveron Life Sciences is a fully integrated biotechnology platform company that invests in people and ideas to develop therapies.See details»
Springbok's Full Body MRI Muscle Health Analysis Named to
22 hours ago Springbok is a life sciences muscle analytics company that drives better health and performance outcomes. Its technology analyzes MRI data and creates …See details»